drugset
drugset / Trial / NCT06880380

The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients

NCT06880380 ↗

Phase 1 Recruiting 3 enrolled Institute of Hematology & Blood Diseases Hospital, China Tsinghua University · collab
NaSingle-groupOpen-labelTreatment

Summary

Autologous CAR-T cell therapy in HIV-1/AIDS patients

Timeline

Start
2025-09-01
Primary completion
2026-03-31
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject HIV-CAR-T Cell therapy — Intravenous

Indications

HIV infectious disease